GlaxoSmithKline Pharmaceuticals Limited Share Price and Company Fundamentals
Last traded: Today at 5:03 AM
GlaxoSmithKline Pharmaceuticals Limited, a healthcare company, researches, develops, manufactures, and sells pharmaceutical medicines and vaccines in India and internationally. The company offers prescription and non-prescription drugs for anti-infective, respiratory, dermatology, nutrition, gastrointestinal, and rare diseases; and consumer healthcare products. It provides its product under the Augmentin, Calpol, Ceftum, Eltroxin, CCM, Neosporin, Betnovate, T-bact, Tenovate, Flutivate, Physiogel, Zimig, Cobadex CZS, Infanrix Hexa, Synflorix, Supacef, Havrix, Menveo, Boostrix, Fluarix Tetra, Varilrix, Nucala, and Trelegy Ellipta brands. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001. GlaxoSmithKline Pharmaceuticals Limited was incorporated in 1924 and is headquartered in Mumbai, India.
Key Metrics
PE ratio
68.14
PB ratio
9.74
Dividend yield
1.94%
Beta
0.18
Market cap
-
Enterprise value
-
Company profile
| Industry / Sector | Drug Manufacturers—General / Healthcare |
|---|---|
| Full time employees | 3840 |
| Website | https://india-pharma.gsk.com |
| Mailing address | GSK House Dr. Annie Besant Road Mumbai 400030 India |
| Phone / Fax | 91 22 2495 9595 / 91 22 2495 9494 |
Dividends
Dividend yield
1.94%
Dividend amount
₹30.00
Payout ratio
133.45%
5Y Avg. yield
1.43%
GlaxoSmithKline Pharmaceuticals Limited paid ₹30.00 dividend and the ex-dividend date was 07 July 2022.The dividend payout ratio is 133.45%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.GLAXO dividend payout ratio is more than 90% making it difficult for the company to maintain the dividends and increase it year by year.
GLAXO's forward dividend amount is ₹30 and the forward dividend yield is 1.94%. A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.
Company Executives
As of Jul 2022, following are the company executives and directors listed on GlaxoSmithKline Pharmaceuticals Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Sridhar Venkatesh | MD & Director | 99.84M | |
| Mr. Juby Chandy | Whole-Time Director & CFO | ||
| Mr. Abhinav Kashyap | VP of Technology & Pharma Technology Lead | ||
| Mr. Ajay A. Nadkarni | VP of Admin. & Real Estate and Company Sec. | ||
| Mr. Sankar Balasubramanian | Ethics & Compliance Officer | ||
| Mr. Amit G. Pandey | Exec. Vice-Pres of Legal | ||
| Mr. Ransom D'Souza | Exec. VP of Communications & Gov. Affairs | ||
| Mr. Chinmay Sharma | Exec. VP of HR | ||
| Mr. Sumer Dheri | Exec. VP of Biologicals | ||
| Mr. Bhushan Akshikar | Commercial Head of Established Pharma Bus. |
Profitability and management effectiveness
Profit margin
51.70%
Operating margin
21.32%
Return on assets
11.27%
Return on equity
18.39%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of GlaxoSmithKline Pharmaceuticals Limited is and its enterprise value is .
The GLAXO's stocks Beta value is 0.18 making it 82% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO) Frequently Asked Questions
1. What is GlaxoSmithKline Pharmaceuticals Limited's Stock Symbol?
GlaxoSmithKline Pharmaceuticals Limited trades on NSE under the ticker symbol "GLAXO".
2. What is GlaxoSmithKline Pharmaceuticals Limited's stock price today?
One share of GLAXO stock can currently be purchased for approximately ₹1485.85.
3. How can I contact GlaxoSmithKline Pharmaceuticals Limited?
GlaxoSmithKline Pharmaceuticals Limited's mailing address is GSK House Dr. Annie Besant Road Mumbai 400030 India. The company can be reached via phone at 91 22 2495 9595.
4. What is GlaxoSmithKline Pharmaceuticals Limited's official website?
The official website of GlaxoSmithKline Pharmaceuticals Limited is https://india-pharma.gsk.com.